JP2005528912A5 - - Google Patents

Download PDF

Info

Publication number
JP2005528912A5
JP2005528912A5 JP2004511476A JP2004511476A JP2005528912A5 JP 2005528912 A5 JP2005528912 A5 JP 2005528912A5 JP 2004511476 A JP2004511476 A JP 2004511476A JP 2004511476 A JP2004511476 A JP 2004511476A JP 2005528912 A5 JP2005528912 A5 JP 2005528912A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
mrna
trans
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004511476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005528912A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/017954 external-priority patent/WO2003104416A2/en
Publication of JP2005528912A publication Critical patent/JP2005528912A/ja
Publication of JP2005528912A5 publication Critical patent/JP2005528912A5/ja
Pending legal-status Critical Current

Links

JP2004511476A 2002-06-05 2003-06-05 幹細胞におけるスプライセオソーム介在ｒｎａトランススプライシング Pending JP2005528912A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38659402P 2002-06-05 2002-06-05
PCT/US2003/017954 WO2003104416A2 (en) 2002-06-05 2003-06-05 Spliceosome mediated rna trans-splicing in stem cells

Publications (2)

Publication Number Publication Date
JP2005528912A JP2005528912A (ja) 2005-09-29
JP2005528912A5 true JP2005528912A5 (enExample) 2006-03-02

Family

ID=29736184

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004511476A Pending JP2005528912A (ja) 2002-06-05 2003-06-05 幹細胞におけるスプライセオソーム介在ｒｎａトランススプライシング

Country Status (6)

Country Link
US (1) US20040180429A1 (enExample)
EP (1) EP1549755A4 (enExample)
JP (1) JP2005528912A (enExample)
AU (1) AU2003247505A1 (enExample)
CA (1) CA2488249A1 (enExample)
WO (1) WO2003104416A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005207053A1 (en) * 2004-01-23 2005-08-04 Virxsys Corporation Expression of ApoA-1 and variants thereof using spliceosome mediated RNA trans-splicing
EP2151248A1 (en) * 2008-07-30 2010-02-10 Johann Bauer Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses
US10987433B2 (en) 2015-11-19 2021-04-27 The Trustees Of The University Of Pennsylvania Compositions and methods for correction of heritable ocular disease
EP3781213A4 (en) 2018-04-17 2022-10-19 The Trustees of the University of Pennsylvania TRANS-SPLICE MOLECULES
WO2022016077A1 (en) * 2020-07-17 2022-01-20 Greenlight Biosciences, Inc. Nucleic acid therapeutics for genetic disorders
CN118786214A (zh) * 2022-01-18 2024-10-15 新加坡国立大学 反式剪接RNA（tsRNA）
CA3252043A1 (en) 2022-05-13 2023-11-16 Ascidian Therapeutics, Inc. ABCA4 TRANS-SPLICING MOLECULES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ241311A (en) * 1991-01-17 1995-03-28 Gen Hospital Corp Rna sequence having trans-splicing activity, plant strains
US6280978B1 (en) * 1995-12-15 2001-08-28 Intronn Holdings, Llc Methods and compositions for use in spliceosome mediated RNA trans-splicing
US6083702A (en) * 1995-12-15 2000-07-04 Intronn Holdings Llc Methods and compositions for use in spliceosome mediated RNA trans-splicing
AU730305B2 (en) * 1995-12-15 2001-03-01 Intronn Llc Therapeutic molecules generated by trans-splicing
CA2278734A1 (en) * 1997-01-23 1998-07-30 Immusol Incorporated Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries

Similar Documents

Publication Publication Date Title
Peselis et al. Structure and function of pseudoknots involved in gene expression control
RU2016123086A (ru) Способы и композиции для лечения болезни хантингтона
JP2004504001A (ja) スプライソソーム媒介ｒｎａトランスースプライシングにおける使用のための方法及び組成物
WO2008145400A3 (en) Mutated structural protein of a parvovirus
WO2005059096A3 (en) Methods for high fidelity production of long nucleic acid molecules with error control
JP2018522566A5 (enExample)
WO2008033413A3 (en) Albumin fusion proteins
WO2007146038A3 (en) Albumin fusion proteins
WO2005077042A3 (en) Albumin fusion proteins
WO2007021494A3 (en) Albumin fusion proteins
JP2009518038A5 (enExample)
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
WO2006032436A3 (en) Use of microproteins as tryptase inhibitors
AU2001260140A1 (en) Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene.
WO2005059097A3 (en) Methods for high fidelity production of long nucleic acid molecules
CA2695061C (en) Sdf-1 binding nucleic acids and the use thereof
JP2005532815A5 (enExample)
JP2013507934A5 (enExample)
JP2005528912A5 (enExample)
Singh New Frontiers and applications of synthetic biology
WO2005097205A3 (en) Dna virus microrna and methods for inhibiting same
JP2010505434A5 (enExample)
JP2004525618A5 (enExample)
WO2002033046A3 (en) Glucose transport-related genes and uses thereof
WO2005100576A3 (en) Replication competent viruses capable of silencing virus inhibitory factor expression